


























![]()
Stoke Therapeutics, Inc. (STOK) Q1 2026 Earnings Call May 7, 2026 4:30 PM EDT
Company Participants
Thomas Leggett - Chief Financial Officer
Ian Smith - CEO & Director
Barry Ticho - Chief Medical Officer
Jason Hoitt - Chief Patient Officer
Conference Call Participants
Pete Stavropoulos - Cantor Fitzgerald & Co., Research Division
Sumant Kulkarni - Canaccord Genuity Corp., Research Division
John Cox - Jefferies LLC, Research Division
Laura Chico - Wedbush Securities Inc., Research Division
Marc Goodman - Leerink Partners LLC, Research Division
Yaron Werber - TD Cowen, Research Division
Thomas Shrader - BTIG, LLC, Research Division
Joseph Stringer - Needham & Company, LLC, Research Division
Adam Ferrari - JPMorgan Chase & Co, Research Division
Yatin Suneja - Guggenheim Securities, LLC, Research Division
Guofang Li - Wolfe Research, LLC
Presentation
Operator
Hello, and thank you for standing by. My name is Bella, and I will be your conference operator today. At this time, I would like to welcome everyone to Stoke Therapeutics First Quarter 2026 Business and Financial Update Conference Call. [Operator Instructions]
I would now like to turn the conference over to Thomas Leggett, Chief Financial Officer. You may begin.
Thomas Leggett
Chief Financial Officer
Good afternoon, and welcome to Stoke Therapeutics first quarter 2026 business update conference call. I'm Thomas Leggett, Chief Financial Officer of Stoke Therapeutics. Joining me on today's call are Ian Smith, our Chief Executive Officer; Dr. Barry Ticho, Chief Medical Officer; and Jason Hoitt, Chief Patient Officer. As a reminder, today's webcast presentation is available in the Investors section of our website. This webcast is being recorded and will be available for replay later this evening.
Before we begin, please note that today's discussion includes forward-looking statements. These forward-looking statements are subject to risks and uncertainties, and actual results may differ materially. Please refer to our filings with the SEC for additional information.
With that, I
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。